InvestorsHub Logo
Followers 11
Posts 2417
Boards Moderated 2
Alias Born 02/24/2018

Re: None

Friday, 03/20/2020 6:22:36 AM

Friday, March 20, 2020 6:22:36 AM

Post# of 205098
To summarize...it is Friday March 20, 2020. We find ourselves in the midst of a global pandemic caused by the coronovirus Covid-19. The demand for testing kits to determine the existence of Covid-19 is currently unmet and health officials and patients are clamoring for the test. The incidence of Covid-19 cases is rising exponentially and many deaths have resulted. The governor of California just ordered the state's residents to stay home. Other governors are contemplating this same decision.

Despite the lack of communications from Arrayit (brought about because of limitations from the SEC Form 15 filed last year) we have been able to learn of certain developments. From the collective due diligence of posters on this board coupled with public information we can assert the following:
. Arrayit has a test for Covid-19
. The test uses Arrayit's finger-stick technology
. Admnistration of the test is very simple and similar (appears identical) to using its Allergy test
. The test has been submitted to the FDA for approval
. Because of current emergency circumstances the test doesn't need FDA approval
. The test can be used now because it is processed at Arrayit's CLIA approved laboratory
. Utilization of tele-medicine is paramount during the pandemic especially because of stay home directives
. We believe Arrayit's finger-stick test can be self-administered in-home via a tele-medicine doctor's prescription for the test

Arrayit appears to be well positioned to provide an invaluable contribution to the challenges brought about by Covid-19.